Document Type : Original Article

Authors

Department of Radiation Oncology, Father Muller Medical College, Mangalore, India

Abstract

Background: Testes being in close proximity to radiation fields in patients of rectal cancer treated with radiotherapy, inadvertently receive a part of the radiation dose. This study was conducted to evaluate the variation of male sex hormones during the course of radiotherapy in patients with rectal cancer.
Method: In this single-institution prospective study, 20 patients with carcinoma rectum were included. The patients were treated with 3-dimensional conformal radiation therapy or intensity modulated radiation therapy technique to a dose of 50.4 Gy for five weeks. Serum testosterone, follicle stimulating hormone (FSH), and luteinizing hormone (LH) levels were obtained prior to and in the meantime of radiotherapy. The post treatment hormone levels were compared to the baseline values. The mean, percentage, standard deviation, and paired t-test were used for statistical analysis.
Results: The mean dose received by the testes was 2.65 Gy (1.96 Gy to 4.96 Gy), which accounted for 5.25% of the total dose. The baseline values of serum testosterone, FSH, and LH were 4.65 ± 0.7 ng/ml, 7.57 ± 1.2 mIU/ml, and 7.93 ± 1.1 mIU/ml, respectively. There was a 32.1% drop in the post treatment testosterone levels compared with the baseline. There was a 77% rise in the post treatment FSH and 40.2% rise in the post treatment LH levels compared with the baseline. There was a significant difference in the rise of LH levels in the patients who received a testicular dose more than 2Gy compared with those who received a dose less than 2 Gy.
Conclusion: Radiation therapy was found to have a significant acute impact on male sex hormones in patients receiving radiotherapy for rectal cancer.

Keywords

How to cite this article:

Krishna A, Fernandes D, Athiyamaan MS, Shankar S, Rao S, Hasib AG. Assessment of variations in serum testosterone, follicle stimulating hormone, and luteinizing hormone levels in patients receiving radiotherapy for rectal cancer. Middle East J Cancer. 2022;13(2):337-42. doi: 10. 30476/mejc.2021.86421.1344.

1. Piroth MD, Hensley F, Wannenmacher M, Zierhut D.
Male gonadal dose in adjuvant 3-d-pelvic irradiation
after anterior resection of rectal cancer. Influence to
fertility. [Article in German] Strahlenther Onkol.
2003;179(11):754-9. doi: 10.1007/s00066-003-1108-y.
2. Amies CJ, Mameghan H, Rose A, Fisher RJ. Testicular
doses in definitive radiation therapy for localized prostate
cancer. Int J Radiat Oncol Biol Phys. 1995;32(3):839-
46. doi: 10.1016/0360-3016(95)00524-3.
3. Dueland S, Guren MG, Olsen DR, Poulsen JP, Magne
Tveit K. Radiation therapy induced changes in male
sex hormone levels in rectal cancer patients. Radiother
Oncol. 2003;68(3):249-53. doi: 10.1016/s0167-
8140(03)00120-8.
4. Hermann RM, Henkel K, Christiansen H, Vorwerk
H, Hille A, Hess CF, et al. Testicular dose and hormonal
changes after radiotherapy of rectal cancer. Radiother
Oncol. 2005;75(1):83-8. doi:10.1016/j.radonc.
2004.12.017.
5. Rowley MJ, Leach DR, Warner GA, Heller CG. Effect
of graded doses of ionizing radiation on the human
testis. Radiat Res. 1974;59(3):665-78.
6. Howell S, Shalet S. Gonadal damage from
chemotherapy and radiotherapy. Endocrinol Metab
Clin North Am. 1998;27(4):927-43. doi:10.1016/s0889-
8529(05)70048-7.
7. Izard MA. Leydig cell function and radiation: a review
of the literature. Radiother Oncol. 1995;34(1):1-8.
doi:10.1016/0167-8140(94)01501-s.
8. Shores MM, Sloan KL, Matsumoto AM, Moceri VM,
Felker B, Kivlahan DR. Increased incidence of
diagnosed depressive illness in hypogonadal older
men. Arch Gen Psychiatry. 2004;61(2):162-7. doi:10.
1001/archpsyc.61.2.162.
9. Svartberg J, von Mühlen D, Schirmer H, Barrett-
Connor E, Sundfjord J, Jorde R. Association of
endogenous testosterone with blood pressure and left
ventricular mass in men. The Tromsø Study. Eur J Endocrinol. 2004;150(1):65-71. doi:10.1530/eje.
0.1500065.
10. Buchli C, Martling A, Arver S, Holm T. Testicular
function after radiotherapy for rectal cancer--a review.
J Sex Med. 2011;8(11):3220-6. doi:10.1111/j.1743-
6109.2011.02455.x.
11. Zagars GK, Pollack A. Serum testosterone levels after
external beam radiation for clinically localized prostate
cancer. Int J Radiat Oncol Biol Phys. 1997;39(1):85-
9. doi:10.1016/s0360-3016(97)00311-8.
12. Tomić R, Bergman B, Damber JE, Littbrand B, Löfroth
PO. Effects of external radiation therapy for cancer
of the prostate on the serum concentrations of
testosterone, follicle-stimulating hormone, luteinizing
hormone and prolactin. J Urol. 1983;130(2):287-9.
doi:10.1016/s0022-5347(17)51110-6.
13. Yoon FH, Perera F, Fisher B, Stitt L. Alterations in
hormone levels after adjuvant chemoradiation in male
rectal cancer patients. Int J Radiat Oncol Biol Phys.
2009;74(4):1186-90. doi:10.1016/j.ijrobp.2008.09.027.
14. Bruheim K, Svartberg J, Carlsen E, Dueland S, Haug
E, Skovlund E, et al. Radiotherapy for rectal cancer
is associated with reduced serum testosterone and
increased FSH and LH. Int J Radiat Oncol Biol Phys.
2008;70(3):722-7. doi:10.1016/j.ijrobp.2007.10.043.
15. Mazonakis M, Damilakis J, Varveris H, Gourtsouiannis
N. Radiation dose to testes and risk of infertility from
radiotherapy for rectal cancer. Oncol Rep. 2006;15(3):
729-33.
16. Buchli C, Al Abani M, Ahlberg M, Holm T, Fokstuen
T, Bottai M, et al. Assessment of testicular dose during
preoperative radiotherapy for rectal cancer. Acta Oncol.
2016;55(4):496-501. doi:10.3109/0284186X.2015.
1073349.
17. Sourati A, Malekzadeh M, Bakhshandeh M,
Moosavizadeh A, Azma Z. Evaluation of relationship
between testicular dose and hormonal changes after
radiotherapy in patients with rectal cancer. Rep
Radiother Oncol. 2015;2(1). doi:10.5812/rro.885.
18. Seal US. FSH and LH elevation after radiation for
treatment of cancer of the prostate. Invest Urol.
1979;16(4):278-80.
19. Hennies S, Wolff HA, Jung K, Rave-Fränk M, Gaedcke
J, Ghadimi M, et al. Testicular radiation dose after
multimodal curative therapy for locally advanced
rectal cancer. Influence on hormone levels, quality of
life, and sexual functioning. Strahlenther Onkol.
2012;188(10):926-32. doi:10.1007/s00066-012-0139-
7.
20. Hahn EW, Feingold SM, Nisce L. Aspermia and
recovery of spermatogenesis in cancer patients
following incidental gonadal irradiation during
treatment: a progress report. Radiology. 1976;119(1):
223-5. doi:10.1148/119.1.223.
21. Ogilvy-Stuart AL, Shalet SM. Effect of radiation on
the human reproductive system. Environ Health
Perspect. 1993;101 Suppl 2(Suppl 2):109-16.
doi:10.1289/ehp.93101s2109.
22. Bruheim K, Guren MG, Dahl AA, Skovlund E,
Balteskard L, Carlsen E, et al. Sexual function in
males after radiotherapy for rectal cancer. Int J Radiat
Oncol Biol Phys. 2010;76(4):1012-1017. doi:10.1016/j.
ijrobp.2009.03.075.
23. Elective clinical target volumes in anorectal cancer:
An RTOG consensus panel contouring atlas. [Internet]
Nrgoncology.org. Published 2020. [Accessed on:
December 15, 2020]. Available at: https://www.
nrgoncology.org/Portals/0/Scientific%20Program/CIR
O/Atlases/AnorectalContouringGuidelines.pdf